Go to New Site

Press Release from Mogrify

Profile

Mogrify wins Hewitsons Award for Innovation in Business and Price Bailey Award for Business of the Year at CambridgeshireLive Business Excellence Awards 2020

Mogrify wins Hewitsons Award for Innovation in Business and Price Bailey Award for Business of the Year at CambridgeshireLive Business Excellence Awards 2020 Awards recognize potential of Mogrify’s technology to accelerate the development of regenerative cell and in vivo reprogramming therapies

Cambridge, UK, 26 March 2021: Mogrify Limited (Mogrify®), a UK company aiming to transform the development of ex vivo cell therapies and pioneer the field of in vivo reprogramming therapies, was awarded the Hewitsons Award for Innovation in Business and Price Bailey Award for Business of the Year at last night’s CambridgeshireLive Business Excellence Awards 2020. The awards recognize the potential of Mogrify’s proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular conversion and the maintenance of cell identity, to accelerate the development of regenerative cell and in vivo reprogramming therapies.

The Company’s technologies, MOGRIFY® and EpiMOGRIFY, deploy next-generation sequencing, gene regulatory and epigenetic network data to enable the prediction of the transcription factors and culture medium conditions required to produce any target cell type from any source cell type.

Mogrify will use these platforms to engineer therapeutic cell types that exhibit efficacy and safety profiles necessary to transform the development of ex vivo cell therapies, and pioneer a new class of in vivo reprogramming therapies for indications of high unmet clinical need in immuno-oncology, ophthalmology and other disease areas.

Uniquely positioned to address a cellular therapy and regenerative medicine market estimated to be worth in excess of $39 billion USD by 2023, Mogrify is commercializing its technology via a combination of internal cell and gene therapy development and collaborations. Since February 2019, Mogrify has raised over $20 million USD in seed and Series A rounds, and $2.5 million USD in grant funding, and has grown to a headcount of over 60 of scientific, operational, and commercial staff.

The CambridgeshireLive Business Excellence Awards are held annually to celebrate businesses and business people in Cambridgeshire and to promote local entrepreneurship and innovation.

Pierre-Louis Joffrin, CDO, Mogrify, said: “We are honored to have been awarded the Hewitsons Award for Innovation in Business and Price Bailey Award for Business of the Year at the CambridgeshireLive Business Excellence Awards. We have an outstanding team of cellular reprogramming experts at Mogrify and this award is testament to their delivery of scientific, commercial and operational excellence.”

For further information on Mogrify, please visit:

https://mogrify.co.uk/about-us/

Posted: 26-Mar-2021

Mogrify
United Kingdom
01223734154 Main
info@mogrify.co.uk Email
25 Cambridge Science Park Milton Road
https://www.mogrify.co.uk website

Hosted By

ELRIG
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG, eventflo.co.uk, Labhoo Ltd 2003-2021